Malignant mesothelioma

Pakistan Journal of Medical Sciences

Volumn 29, Issue 6, 2013, Pages

  Ahmed, Ishtiaq ^a   Tipu, Salman Ahmed ^a   Ishtiaq, Sundas ^b  

^a Al Nafees Medical College   (Pakistan)

^b Women Medical College Pakistan   (Pakistan)

Author keywords

Asbestos; Malignant mesothelioma; Peritoneum; Surgery

Indexed keywords

ALPHA2A INTERFERON; ANTINEOPLASTIC AGENT; ASBESTOS; AUTOVACCINE; CISPLATIN; DOXORUBICIN; FLUOROURACIL; GEFITINIB; GEMCITABINE; IRINOTECAN; MITOMYCIN; NAVELBINE; OKT 3; PACLITAXEL; PEMETREXED; PLATINUM COMPLEX;

CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CANCER THERAPY; CLINICAL FEATURE; CONTINUOUS INFUSION; CROSS-SECTIONAL STUDY; CYTOTOXIC T LYMPHOCYTE; DELAYED DIAGNOSIS; DISEASE COURSE; FATALITY; GENE THERAPY; HISTOPATHOLOGY; HUMAN; HYPERTHERMIC THERAPY; IMMUNOHISTOCHEMISTRY; INDUSTRY; LAPAROSCOPY; MALIGNANT MESOTHELIOMA; PATHOGENESIS; PERICARDIUM; PERITONEUM; PERITONEUM MESOTHELIOMA; PHASE 2 CLINICAL TRIAL (TOPIC); PHOTODYNAMIC THERAPY; PLEURA; PLEURA MESOTHELIOMA; POLLUTION; REVIEW; SYMPTOM; TUMOR BIOPSY; TUNICA VAGINALIS;

EID: 84885926511     PISSN: 1682024X     EISSN: None     Source Type: Journal    
DOI: 10.12669/pjms.296.3938     Document Type: Review

References (44)

1. Bridda A, Padoan I, Mencarelli R, Frego M. Peritoneal Mesothelioma: A Review. Med Gen Med. 2007;9(2):32.
2. Cunha P, Luz Z, Seves I. Malignant peritoneal mesothelioma - diagnostic and therapeutic difficulties. Acta Med Port. 2002;15:383-386.
3. Bianchi C, Bianchi T. Malignant mesothelioma: global incidence and relationship with asbestos. Industrial Health. 2007;45(3):379-387.
4. Robinson BW, Lake RA. Advances in malignant mesothelioma. N Engl J Med. 2005;353:1591-1603.
5. Boffetta P. Epidemiology of peritoneal mesothelioma: a review. Annals Oncol. 2007;18(6):985-990.
6. De Pangher Manzini V. Malignant peritoneal mesothelioma. Tumori. 2005;91:1-5.
7. Ahmed I, Koulaouzidis A, Iqbal J, Tan WC. Malignant peritoneal mesothelioma as a rare cause of ascites: a case report. J Med Case Reports. 2008;2:121.
8. Teta MJ, Mink PJ, Lane E. US mesothelioma pattern 1973-2002: indicators of change and insight into background rate. Eu J Cancer Prev. 2008;17:525.
9. Rodríguez D, Cheung MC, Housri N, Koniaris LG. Malignant abdominal mesothelioma: defining the role of surgery. J Surg Oncol. 2009;99(1):51.
10. Brigand C, Monneuse O, Mohamed F. Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study. Ann Surg Oncol. 2006;13:405-412.
11. Levy AD, Arnáiz J, Shaw JC, Sobin LH. From the archives of the AFIP: primary peritoneal tumors: imaging features with pathologic correlation. Radiographics. 2008;28(2):583.
12. Baker PM, Clement PB, Young RH. Malignant peritoneal mesothelioma in women: a study of 75 cases with emphasis on their morphologic spectrum and differential diagnosis. Am J Clin Pathol. 2005;123:724-737.
13. Galateau-Salle, Francoise. Pathology of Malignant Mesothelioma. Springer-Verlag London Limited: London. 2006.
14. Borasio P, Berruti A, Billé A. Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients. Eur J Cardiothorac Surg. 2008;33(2):307-313.
15. Murthy SS, Testa JR. Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma. J Cell Physiol. 1999;180(2):150-157.
16. Busch JM, Kruskal JB, Wu B. Armed Forces Institute of Pathology Best cases from the AFIP. Malignant peritoneal mesothelioma. Radiographics. 2002;22:1511-1515.
17. American Cancer Society. Malignant Mesothelioma Overview. 2012. Retrieved from website: http://www.cancer.org/acs/groups/cid/documents/webcontent/003062-pdf.pdf.
18. International Mesothelioma Symposium Presentation. 2011 Retrieved from: website: http://www.curemeso.org/site/c.kkLUJ7MPKtH/b.7634491/k.86EF/2011_Symposium_Presentations/apps/nl/newsletter.asp.
19. American Cancer Society. Malignant Mesothelioma Overview. 2012. Retrieved from website: http://www.cancer.org/acs/groups/cid/documents/webcontent/003062-pdf.pdf
20. Pickhardt PJ, Bhalla S. Primary neoplasms of peritoneal and sub-peritoneal origin: CT findings. Radiographics. 2005;25:983-995.
21. Sugarbaker PH, Acherman YI, Gonzalez-Moreno S. Diagnosis and treatment of peritoneal mesothelioma: The Washington Cancer Institute experience. Semin Oncol. 2002;29:51-61.
22. Edwards JG, Abrams KR, Leverment JN. Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems. Thorax. 2000;55(9):731-735.
23. Sterman DH. Advances in management of mesothelioma. Respirology. 2005;10:266-283.
24. Kusamura S, Younan R, Baratti D. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique. Cancer. 2006;106:1144-1153.
25. Konstantinidis IT, Young C, Tsikitis VL, Lee E, Jie T, Ong ES. Cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion: The University of Arizona early experience. World J Gastrointest Surg. 2012;27(6):135-140.
26. Hotta T, Taniguchi K, Kobayashi Y. Chemotherapy and serum hyaluronic acid levels in malignant peritoneal mesothelioma. Hepatogastroenterology. 2004;51:1073-1083.
27. Le DT, Deavers M, Hunt K, Malpica A, Verschraegen CF. Cisplatin and irinotecan (CPT-11) for peritoneal mesothelioma. Cancer Invest. 2003;21:682-689.
28. Deraco M, Kusamura S, Baratti D, Casali P, Zaffaroni N. Peritoneal mesothelioma: results of a complicated and aggressive procedure incorporating peritonectomy and intraperitoneal hyperthermic chemotherapy, and prospects derived from bench-to-bedside research. Tumori. 2003;89:56-57.
29. Baratti D, Kusamura S, Cabras AD, Laterza B, Balestra MR, Deraco M. Lymph node metastases in diffuse malignant peritoneal mesothelioma. Ann Surg Oncol. 2010;17(1):45-53.
30. Casado-Adam A, Alderman R, Stuart OA, Chang D, Sugarbaker PH. Gastrointestinal complications in 147 consecutive patients with peritoneal surface malignancy treated by cytoreductive surgery and perioperative intraperitoneal chemotherapy. Int J Surg Oncol. 2011;2011:468698.
31. Sugarbaker PH, Yan TD, Stuart OA, Yoo D. Comprehensive management of diffuse malignant peritoneal mesothelioma. Eur J Surg Oncol 2006;32:686-91.
32. Garcia-Carbonero R, Paz-Ares L. Systemic chemotherapy in the management of malignant peritoneal mesothelioma. Eur J Surg Oncol. 2006;32:676-681.
33. Janne PA, Wozniak AJ, Belani CP. Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program. Clin Lung Cancer. 2005;7:40-46.
34. Hada M, Kazuhiro M. A case report of disseminated malignant mesothelioma of peritoneum responding remarkably to thalidomide, celecoxib, vinorelbine and CDDP Gan To Kagaku Ryoho. 2004;31:2191-2194.
35. Kindler HL, Herndon JE, Zhang C, Green MR. Cancer and Leukemia Group B Irinotecan for malignant mesothelioma A phase II trial by the Cancer and Leukemia Group B. Lung Cancer. 2005;48:423-428.
36. Govindan R, Kratzke RA, Herndon JE. For the Cancer and Leukemia Group B (CALGB 30101) Gefitinib in patients with malignant mesothelioma: a phase II study by the Cancer and Leukemia Group B. Clin Cancer Res. 2005;11:2300-2304.
37. Hesdorffer ME, Chabot JA, Keohan ML, Fountain K, Talbot S, Gabay M, et al. Combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for the treatment of malignant peritoneal mesothelioma. Am J Clin Oncol. 2008;31(1):49-54.
38. Robinson BW, Musk AW, Lake RA. Malignant mesothelioma. Lancet. 2005;366:397-408.
39. Schlom J. Therapeutic cancer vaccines: Current status and moving forward. J Natl Cancer Inst. 2012;104(8):599-613.
40. Hodge JW, Schlom J, Abrams SI. Vaccines and immunostimulants. In: Kufe DW, Bast RC, Hait WN, Hong WK, Pollock RE, Weichselbaum RR, Holland JF, Frei E, eds. Cancer Medicine 7. Hamilton, Ontario: BC Decker, Inc. 2006:786-801.
41. American Cancer Society. (2012 January 12). What's New in Malignant Mesothelioma Research? 2012 Retrieved from web site: http://www.cancer.org/Cancer/MalignantMesothelioma/DetailedGuide/malignant-mesothelioma-new-research
42. Abramson Cancer Center of the University of Pennsylvania. Gene Therapy: The Basics. 2010 Retrieved from website: http://www.oncolink.org/treatment/article.cfm?c=15&s=110&id=323
43. Demmy TL. Surgery and Photodynamic Therapy in Treating Patients With Malignant Mesothelioma. 2011. Retrieved from website: http://clinicaltrials.gov/ct2/show/NCT00054002
44. Mirabelli D, Roberti S, Gangemi M. Survival of peritoneal malignant mesothelioma in Italy: a population-based study. Int J Cancer. 2009;124:194e200.